Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
3429
-
Total 13F shares, excl. options
-
1.91B
-
Shares change
-
-44.9M
-
Total reported value, excl. options
-
$217B
-
Value change
-
-$5.51B
-
Put/Call ratio
-
0.91
-
Number of buys
-
1591
-
Number of sells
-
-1554
-
Price
-
$113.56
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q3 2024
3,700 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q3 2024.
Merck & Co., Inc. - Common Stock (MRK) has 3,429 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.91B shares
of 2.53B outstanding shares and own 75.56% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (250M shares), BlackRock, Inc. (212M shares), STATE STREET CORP (119M shares), WELLINGTON MANAGEMENT GROUP LLP (75.8M shares), GEODE CAPITAL MANAGEMENT, LLC (59.2M shares), FMR LLC (49.7M shares), MORGAN STANLEY (44.4M shares), BANK OF AMERICA CORP /DE/ (38.9M shares), JPMORGAN CHASE & CO (27.3M shares), and NORTHERN TRUST CORP (26.9M shares).
This table shows the top 3429 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.